Abstract
Developmentally regulated changes in the immature brain may contribute to an age-related period of susceptibility to seizures and brain injury resulting from impaired brain perfusion. It is therefore crucial that immature animal models be developed that are relevant to ischemic injury in the immature brain as an important cause of neurologic morbidity. We review here the animal models for ischemic injury in the immature brain with a focus on rodent models. These models have begun to be used for neuroprotective studies. Of the findings from these pre-clinical studies, a few interventions, including hypothermia and magnesium, have been studied in clinical trials. The published results so far from these clinical studies are reviewed here as well. More pre-clinical and clinical studies are needed to assess approaches to preventing ischemic brain injury in term neonates, infants, and children.
Keywords: ischemia, stroke, immature brain, seizures, neuroprotection
Current Pediatric Reviews
Title: Neuroprotection for Ischemic Injury in the Immature Brain
Volume: 1 Issue: 2
Author(s): Anne M. Comi
Affiliation:
Keywords: ischemia, stroke, immature brain, seizures, neuroprotection
Abstract: Developmentally regulated changes in the immature brain may contribute to an age-related period of susceptibility to seizures and brain injury resulting from impaired brain perfusion. It is therefore crucial that immature animal models be developed that are relevant to ischemic injury in the immature brain as an important cause of neurologic morbidity. We review here the animal models for ischemic injury in the immature brain with a focus on rodent models. These models have begun to be used for neuroprotective studies. Of the findings from these pre-clinical studies, a few interventions, including hypothermia and magnesium, have been studied in clinical trials. The published results so far from these clinical studies are reviewed here as well. More pre-clinical and clinical studies are needed to assess approaches to preventing ischemic brain injury in term neonates, infants, and children.
Export Options
About this article
Cite this article as:
Comi M. Anne, Neuroprotection for Ischemic Injury in the Immature Brain, Current Pediatric Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573396054065448
DOI https://dx.doi.org/10.2174/1573396054065448 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Inflammatory Treatments for Chronic Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Efficacy and Safety Profile of Aliskiren: Practical Implications for Clinicians
Current Drug Safety The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury
Current Medicinal Chemistry Tissue Plasminogen Activator Prevents Restoration of Tight Junction Proteins Through Upregulation of Angiopoietin-2
Current Neurovascular Research Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging Recent Advances in Image-Based Stem-Cell Labeling and Tracking, and Scaffold-Based Organ Development in Cardiovascular Disease
Recent Patents on Medical Imaging The Genetic Basis of New Treatment Modalities in Melanoma
Current Drug Targets Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntingtons Disease Phenotype
CNS & Neurological Disorders - Drug Targets Cyclooxygenase-2 in Synaptic Signaling
Current Pharmaceutical Design Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Current Pharmaceutical Design Arboviral Encephalitis and RNAi Treatment
Central Nervous System Agents in Medicinal Chemistry Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson`s Disease
CNS & Neurological Disorders - Drug Targets Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?
CNS & Neurological Disorders - Drug Targets Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment
Anti-Cancer Agents in Medicinal Chemistry Lactones: Generic Inhibitors of Enzymes?
Mini-Reviews in Medicinal Chemistry Differential Regulation of microRNAs in Patients with Ischemic Stroke
Current Neurovascular Research Biologics: An Update and Challenge of Their Pharmacokinetics
Current Drug Metabolism The Rise and Fall of NMDA Antagonists for Ischemic Stroke
Current Molecular Medicine